{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:43:05Z","timestamp":1790786585628,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases","award":["2020B1212060017"],"award-info":[{"award-number":["2020B1212060017"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873751"],"award-info":[{"award-number":["81873751"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071255"],"award-info":[{"award-number":["82071255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Provincial Clinical Research Center for Neurological Diseases","award":["2020B1111170002"],"award-info":[{"award-number":["2020B1111170002"]}]},{"name":"Southern China International Joint Research Center for Early Intervention and Functional Rehabilitation of Neurological Diseases","award":["2015B050501003"],"award-info":[{"award-number":["2015B050501003"]}]},{"name":"Southern China International Joint Research Center for Early Intervention and Functional Rehabilitation of Neurological Diseases","award":["2020A0505020004"],"award-info":[{"award-number":["2020A0505020004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10072-023-07179-9","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T03:02:36Z","timestamp":1700190156000},"page":"2047-2055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Real-world experience with Deutetrabenazine management in patients with Huntington\u2019s disease using video-based telemedicine"],"prefix":"10.1007","volume":"45","author":[{"given":"Lishan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengteng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7326-9877","authenticated-orcid":false,"given":"Dingbang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"issue":"8","key":"7179_CR1","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamaneurol.2020.1973","volume":"77","author":"BR Leavitt","year":"2020","unstructured":"Leavitt BR, Kordasiewicz HB, Schobel SA (2020) Huntington-lowering therapies for Huntington disease: a review of the evidence of potential benefits and risks (vol 57, pg 612, 2020). Jama Neurol 77(8):1040. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1973","journal-title":"Jama Neurol"},{"issue":"10","key":"7179_CR2","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1002\/mds.28650","volume":"36","author":"PM Abeyasinghe","year":"2021","unstructured":"Abeyasinghe PM, Long JD, Razi A, Pustina D, Paulsen JS, Tabrizi SJ, Poudel GR, Georgiou-Karistianis N (2021) Tracking Huntington\u2019s disease progression using motor, functional, cognitive, and imaging markers. Movement Disord 36(10):2282\u20132292. https:\/\/doi.org\/10.1002\/mds.28650","journal-title":"Movement Disord"},{"issue":"1","key":"7179_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jnnp.56.1.98","volume":"56","author":"RA Roos","year":"1993","unstructured":"Roos RA, Hermans J, Vegter-van der Vlis M, van Ommen GJ, Bruyn GW (1993) Duration of illness in Huntington\u2019s disease is not related to age at onset. J Neurol Neurosurg Psychiatry 56(1):98\u2013100. https:\/\/doi.org\/10.1136\/jnnp.56.1.98","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"7179_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L, Steeves T, Jette N (2012) The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Movement Disord J Movement Disord Soc 27(9):1083\u20131091. https:\/\/doi.org\/10.1002\/mds.25075","journal-title":"Movement Disord J Movement Disord Soc"},{"issue":"3","key":"7179_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000109899","volume":"15","author":"K Nakashima","year":"1996","unstructured":"Nakashima K, Watanabe Y, Kusumi M, Nanba E, Maeoka Y, Nakagawa M, Igo M, Irie H, Ishino H, Fujimoto A, Goto J, Takahashi K (1996) Epidemiological and genetic studies of Huntington\u2019s disease in the San-in area of Japan. Neuroepidemiology 15(3):126\u2013131. https:\/\/doi.org\/10.1159\/000109899","journal-title":"Neuroepidemiology"},{"issue":"5","key":"7179_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.14336\/AD.2018.0911","volume":"10","author":"HL Li","year":"2019","unstructured":"Li HL, Li XY, Dong Y, Zhang YB, Cheng HR, Gan SR, Liu ZJ, Ni W, Burgunder JM, Yang XW, Wu ZY (2019) Clinical and genetic profiles in Chinese patients with Huntington\u2019s disease: a ten-year multicenter study in China. Aging Dis 10(5):1003\u20131011. https:\/\/doi.org\/10.14336\/AD.2018.0911","journal-title":"Aging Dis"},{"key":"7179_CR7","first-page":"43","volume":"31","author":"CM Chang","year":"1994","unstructured":"Chang CM, Yu YL, Fong KY, Wong MT, Chan YW, Ng TH, Leung CM, Chan V (1994) Huntington\u2019s disease in Hong Kong Chinese: epidemiology and clinical picture. Clin Exp Neurol 31:43\u201351","journal-title":"Clin Exp Neurol"},{"issue":"4","key":"7179_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000319462","volume":"35","author":"YY Chen","year":"2010","unstructured":"Chen YY, Lai CH (2010) Nationwide population-based epidemiologic study of Huntington\u2019s disease in Taiwan. Neuroepidemiology 35(4):250\u2013254. https:\/\/doi.org\/10.1159\/000319462","journal-title":"Neuroepidemiology"},{"issue":"1","key":"7179_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2478\/jtim-2022-0006","volume":"10","author":"L Lin","year":"2022","unstructured":"Lin L, Su F, Chen D, Pei Z (2022) The first patient with sporadic Huntington\u2019s disease due to a de novo (CAG)n expansion in China. J Transl Int Med 10(1):76\u201378. https:\/\/doi.org\/10.2478\/jtim-2022-0006","journal-title":"J Transl Int Med"},{"issue":"2","key":"7179_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1212\/wnl.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JJ, Siemers E, Shoulson I (2000) Rate of functional decline in Huntington\u2019s disease. Huntington Stud Group Neurol 54(2):452\u2013458. https:\/\/doi.org\/10.1212\/wnl.54.2.452","journal-title":"Huntington Stud Group Neurol"},{"issue":"12","key":"7179_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/jnnp.2010.209668","volume":"82","author":"M Orth","year":"2011","unstructured":"Orth M, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB (2011) Observing Huntington\u2019s disease: the European Huntington\u2019s disease network\u2019s registry. J Neurol Neurosurg Psychiatry 82(12):1409\u20131412. https:\/\/doi.org\/10.1136\/jnnp.2010.209668","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7179_CR12","doi-asserted-by":"publisher","unstructured":"Ke HY, Cao X, Song YY, Cao L (2021) Health services utilization of Chinese patients with Huntington\u2019s disease: a cross-sectional study. Bmc Health Serv Res 21(1). https:\/\/doi.org\/10.1186\/s12913-021-06826-1","DOI":"10.1186\/s12913-021-06826-1"},{"issue":"7","key":"7179_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1474-4422(17)30167-9","volume":"16","author":"RB Schneider","year":"2017","unstructured":"Schneider RB, Biglan KM (2017) The promise of telemedicine for chronic neurological disorders: the example of Parkinson\u2019s disease. Lancet Neurol 16(7):541\u2013551. https:\/\/doi.org\/10.1016\/S1474-4422(17)30167-9","journal-title":"Lancet Neurol"},{"issue":"5","key":"7179_CR14","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.jaip.2021.01.036","volume":"9","author":"SS Mustafa","year":"2021","unstructured":"Mustafa SS, Vadamalai K, Ramsey A (2021) Patient satisfaction with in-person, video, and telephone allergy\/immunology evaluations during the COVID-19 pandemic. J Aller Cl Imm-Pract 9(5):1858\u20131863. https:\/\/doi.org\/10.1016\/j.jaip.2021.01.036","journal-title":"J Aller Cl Imm-Pract"},{"issue":"1","key":"7179_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1470-2045(19)30675-8","volume":"21","author":"A van der Hout","year":"2020","unstructured":"van der Hout A, van Uden-Kraan CF, Holtmaat K, Jansen F, Lissenberg-Witte BI, Nieuwenhuijzen G, Hardillo JA, de Jong R, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee R, Bosscha K, van den Brekel M, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein S, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-De Leeuw IM (2020) Role of ehealth application oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol 21(1):80\u201394. https:\/\/doi.org\/10.1016\/S1470-2045(19)30675-8","journal-title":"Lancet Oncol"},{"issue":"11","key":"7179_CR16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk NM, de Vries NM, Kessels R, Joosten H, Zwinderman AH, Post B, Bloem BR (2019) Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol 18(11):998\u20131008. https:\/\/doi.org\/10.1016\/S1474-4422(19)30285-6","journal-title":"Lancet Neurol"},{"issue":"16","key":"7179_CR17","doi-asserted-by":"publisher","first-page":"E1764","DOI":"10.1212\/WNL.0000000000009292","volume":"94","author":"RD Dobkin","year":"2020","unstructured":"Dobkin RD, Mann SL, Gara MA, Interian A, Rodriguez KM, Menza M (2020) Telephone-based cognitive behavioral therapy for depression in Parkinson disease a randomized controlled trial. Neurology 94(16):E1764\u2013E1773. https:\/\/doi.org\/10.1212\/WNL.0000000000009292","journal-title":"Neurology"},{"issue":"5","key":"7179_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/tmj.2020.0316","volume":"27","author":"MB Harrison","year":"2021","unstructured":"Harrison MB, Morrissey D (2021) Interdisciplinary telemedicine services for Huntington\u2019s disease: a 20-year experience. Telemed E-Health 27(5):583\u2013586. https:\/\/doi.org\/10.1089\/tmj.2020.0316","journal-title":"Telemed E-Health"},{"issue":"2","key":"7179_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3233\/JHD-140102","volume":"3","author":"MT Bull","year":"2014","unstructured":"Bull MT, Darwin K, Venkataraman V, Wagner J, Beck CA, Dorsey ER, Biglan KM (2014) A pilot study of virtual visits in huntington disease. J Huntingtons Dis 3(2):189\u2013195. https:\/\/doi.org\/10.3233\/JHD-140102","journal-title":"J Huntingtons Dis"},{"issue":"3","key":"7179_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2478\/jtim-2019-0019","volume":"7","author":"B Hu","year":"2019","unstructured":"Hu B (2019) Application of wearable technology in clinical walking and dual task testing. J Transl Int Med 7(3):87\u201389. https:\/\/doi.org\/10.2478\/jtim-2019-0019","journal-title":"J Transl Int Med"},{"issue":"7","key":"7179_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, Estevez-Fraga C, van Roon-Mom W, Flower MD, Scahill RI, Wild EJ, Munoz-Sanjuan I, Sampaio C, Rosser AE, Leavitt BR (2022) Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol 21(7):645\u2013658. https:\/\/doi.org\/10.1016\/S1474-4422(22)00121-1","journal-title":"Lancet Neurol"},{"issue":"1","key":"7179_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jama.2016.8655","volume":"316","author":"S Frank","year":"2016","unstructured":"Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O\u2019Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora FJ, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, Mcgarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, Lafaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E (2016) Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial. JAMA 316(1):40\u201350. https:\/\/doi.org\/10.1001\/jama.2016.8655","journal-title":"JAMA"},{"issue":"10","key":"7179_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1212\/01.wnl.0000259143.52138.5c","volume":"68","author":"AA Savani","year":"2007","unstructured":"Savani AA, Login IS (2007) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 68(10):797\u2013797. https:\/\/doi.org\/10.1212\/01.wnl.0000259143.52138.5c","journal-title":"Neurology"},{"issue":"10","key":"7179_CR24","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/mds.25362","volume":"28","author":"Huntington Study Group HART Investigators","year":"2013","unstructured":"Huntington Study Group HART Investigators (2013) A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington\u2019s disease. Mov Disord 28(10):1407\u20131415. https:\/\/doi.org\/10.1002\/mds.25362","journal-title":"Mov Disord"},{"issue":"1","key":"7179_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.23953","volume":"27","author":"CS Venuto","year":"2012","unstructured":"Venuto CS, Mcgarry A, Ma Q, Kieburtz K (2012) Pharmacologic approaches to the treatment of Huntington\u2019s disease. Movement Disord 27(1):31\u201341. https:\/\/doi.org\/10.1002\/mds.23953","journal-title":"Movement Disord"},{"issue":"5","key":"7179_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40271-018-0312-x","volume":"11","author":"EM Thorley","year":"2018","unstructured":"Thorley EM, Iyer RG, Wicks P, Curran C, Gandhi SK, Abler V, Anderson KE, Carlozzi NE (2018) Understanding how chorea affects health-related quality of life in Huntington disease: an online survey of patients and caregivers in the United States. Patient 11(5):547\u2013559. https:\/\/doi.org\/10.1007\/s40271-018-0312-x","journal-title":"Patient"},{"issue":"5","key":"7179_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/mds.27317","volume":"33","author":"TA Mestre","year":"2018","unstructured":"Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT (2018) Quality of life in Huntington\u2019s disease: critique and recommendations for measures assessing patient health-related quality of life and caregiver quality of life. Movement Disord 33(5):742\u2013749. https:\/\/doi.org\/10.1002\/mds.27317","journal-title":"Movement Disord"},{"issue":"17","key":"7179_CR28","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s40265-017-0831-0","volume":"77","author":"YA Heo","year":"2017","unstructured":"Heo YA, Scott LJ (2017) Deutetrabenazine: a review in chorea associated with Huntington\u2019s disease. Drugs 77(17):1857\u20131864. https:\/\/doi.org\/10.1007\/s40265-017-0831-0","journal-title":"Drugs"},{"key":"7179_CR29","doi-asserted-by":"publisher","unstructured":"Cheng Y, Gu X, Liu K, Yang T, Xiao Y, Jiang Q, Huang J, Lin J, Wei Q, Ou R, Hou Y, Zhang L, Li C, Burgunder JM, Shang H (2022) The comprehensive analysis of motor and neuropsychiatric symptoms in patients with Huntington\u2019s disease from China: a cross-sectional study. J Clin Med 12(1). https:\/\/doi.org\/10.3390\/jcm12010206","DOI":"10.3390\/jcm12010206"},{"key":"7179_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jpsychires.2021.07.024","volume":"141","author":"XY Li","year":"2021","unstructured":"Li XY, Gao B, Xie JJ, Bao YF, Dong Y, Wu ZY (2021) The clinical, imaging and biological features of psychosis in Han Chinese patients with Huntington\u2019s disease. J Psychiatr Res 141:333\u2013338. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.07.024","journal-title":"J Psychiatr Res"},{"issue":"11","key":"7179_CR31","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s40263-022-00956-8","volume":"36","author":"S Frank","year":"2022","unstructured":"Frank S, Testa C, Edmondson MC, Goldstein J, Kayson E, Leavitt BR, Oakes D, O\u2019Neill C, Vaughan C, Whaley J, Gross N, Gordon MF, Savola JM (2022) The safety of deutetrabenazine for chorea in Huntington disease: an open-label extension study. CNS Drugs 36(11):1207\u20131216. https:\/\/doi.org\/10.1007\/s40263-022-00956-8","journal-title":"CNS Drugs"},{"key":"7179_CR32","doi-asserted-by":"publisher","unstructured":"Koch J, Shi WX, Dashtipour K (2020) Vmat2 inhibitors for the treatment of hyperkinetic movement disorders. Pharmacol Therapeut 212. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107580","DOI":"10.1016\/j.pharmthera.2020.107580"},{"issue":"8","key":"7179_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/14737175.2018.1500178","volume":"18","author":"H Bashir","year":"2018","unstructured":"Bashir H, Jankovic J (2018) Deutetrabenazine for the treatment of Huntington\u2019s chorea. Expert Rev Neurother 18(8):625\u2013631. https:\/\/doi.org\/10.1080\/14737175.2018.1500178","journal-title":"Expert Rev Neurother"},{"key":"7179_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/DDDT.S138828","volume":"12","author":"M Dean","year":"2018","unstructured":"Dean M, Sung VW (2018) Review of deutetrabenazine: a novel treatment for chorea associated with Huntington\u2019s disease. Drug Des Dev Ther 12:313\u2013319. https:\/\/doi.org\/10.2147\/DDDT.S138828","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"7179_CR35","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/mds.22412","volume":"24","author":"AK Ho","year":"2009","unstructured":"Ho AK, Gilbert AS, Mason SL, Goodman AO, Berker RA (2009) Health-related quality of life in Huntington\u2019s disease: which factors matter most? Movement Disord 24(4):574\u2013578. https:\/\/doi.org\/10.1002\/mds.22412","journal-title":"Movement Disord"},{"issue":"8","key":"7179_CR36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/jamaneurol.2017.1352","volume":"74","author":"S Frank","year":"2017","unstructured":"Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM (2017) Safety of converting from tetrabenazine to deutetrabenazine for the treatment of chorea. Jama Neurol 74(8):977\u2013982. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1352","journal-title":"Jama Neurol"},{"issue":"12","key":"7179_CR37","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1136\/jnnp-2018-319918","volume":"90","author":"HH Fernandez","year":"2019","unstructured":"Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, Bega D, Ledoux MS, Shprecher DR, Anderson KE (2019) Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. J Neurol Neurosurg Psychiatry 90(12):1317\u20131323. https:\/\/doi.org\/10.1136\/jnnp-2018-319918","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"7179_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S2215-0366(17)30236-5","volume":"4","author":"KE Anderson","year":"2017","unstructured":"Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojarvi J, Jarskog LF, Jimenez-Shahed J, Kumar R, Mcevoy JP, Ochudlo S, Ondo WG, Fernandez HH (2017) Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (aim-td): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Psychiat 4(8):595\u2013604. https:\/\/doi.org\/10.1016\/S2215-0366(17)30236-5","journal-title":"Lancet Psychiat"},{"issue":"12","key":"7179_CR39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jmg.29.12.911","volume":"29","author":"SA Sorensen","year":"1992","unstructured":"Sorensen SA, Fenger K (1992) Causes of death in patients with Huntington\u2019s disease and in unaffected first degree relatives. J Med Genet 29(12):911\u2013914. https:\/\/doi.org\/10.1136\/jmg.29.12.911","journal-title":"J Med Genet"},{"issue":"6","key":"7179_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5694\/j.1326-5377.1966.tb73569.x","volume":"2","author":"C Edmonds","year":"1966","unstructured":"Edmonds C (1966) Huntington\u2019s chorea, dysphagia and death. Med J Aust 2(6):273\u2013274. https:\/\/doi.org\/10.5694\/j.1326-5377.1966.tb73569.x","journal-title":"Med J Aust"},{"issue":"5","key":"7179_CR41","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1212\/wnl.38.5.769","volume":"38","author":"DJ Lanska","year":"1988","unstructured":"Lanska DJ, Lavine L, Lanska MJ, Schoenberg BS (1988) Huntington\u2019s disease mortality in the United States. Neurology 38(5):769\u2013772. https:\/\/doi.org\/10.1212\/wnl.38.5.769","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07179-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:34:29Z","timestamp":1713242069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07179-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["7179"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07179-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Independent Ethics Committee for Clinical Research and Animal Trials of our hospital (approval number: [2022]594). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants were provided with written informed consents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The participants have consented to the submission of their data report to the journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}